Cited 4 times in
A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.